Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

C1, MBL–MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation

19 Nov 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
Share to Complement system in diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18977695
DOI: 10.1016/j.molmed.2008.09.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

C1, MBL–MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammationPMID 18977695Read ↗

The alternative pathway of complement in disease: opportunities for therapeutic targetingSemantic proximity Read ↗

C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement FunctionsSemantic proximity Read ↗

C1q as a target molecule to treat human disease: What do mouse studies teach us?Semantic proximity Read ↗

Understanding the contextual functions of C1q and LAIR-1 and their applicationsSemantic proximity Read ↗

Complement‐targeted therapeutics: Are we there yet, or just getting started?Semantic proximity Read ↗

Novel potential inhibitors of complement system and their roles in complement regulation and beyondSemantic proximity Read ↗

Therapeutic targeting of the complement systemSemantic proximity Read ↗

First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunitiesSemantic proximity Read ↗

Complement inhibitors: a resurgent concept in anti-inflammatory therapeuticsSemantic proximity Read ↗

Complement in Immune and Inflammatory Disorders: Therapeutic InterventionsSemantic proximity Read ↗

Review: The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune DiseasesSemantic proximity Read ↗

Complement‐targeted therapeutics: An emerging field enabled by academic drug discoverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.